missing translation for 'onlineSavingsMsg'
Learn More

Alpaca monoclonal [2F3] Anti-human IgG1/IgG4 antibody (ATTO 488), Abcam

Artikelnummer. 32114418 Alle ansehen Abcam Produkte
Ansicht ändern
Click to view available options
Menge:
100 μL
Packungsgröße:
100 Mikroliter
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Menge Packungsgröße
32114418 100 μL 100 Mikroliter
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Artikelnummer. 32114418 Lieferant Abcam Lieferanten-Nr. ab325309100uL
 Eingeschränkter Artikel
Verfügbar ab: 24-11-2026
Zum Warenkorb hinzufügen
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

Alpaca Monoclonal Antibody

Recombinant secondary antibody suitable for ICC/IF.

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Antigen IGG1_HUMAN (IGG1)
Anwendungen Immunocytochemistry/Immunofluorescence
Zelluläre Lokalisierung Secreted; Cell membrane
Klassifikation Monoclonal
Klon '2F3
Konjugat Atto 488
Zusammensetzung Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Gen IGG1_HUMAN
Gen-Zugriffsnummer P0DOX5
Wirtsspezies Alpaca
Immunogen IGG1_HUMAN (IGG1)
Reinigungsverfahren Size-exclusion chromatography
Menge 100 μL
Regulatorischer Status RUO
Primär oder sekundär Secondary
Zielspezies Human
Inhalt und Lagerung -80°C
Produkttyp Primary Antibody
Form Liquid
Isotype IgG
Versandbedingung Blue Ice
Zielgen IGG1_HUMAN
Zielmolekül IGG1_HUMAN (IGG1)
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.